Search for: "CELGENE"
Results 21 - 40
of 183
Sort by Relevance
|
Sort by Date
3 Mar 2021, 4:58 pm
But a compulsory license has not been first ever made: previously, compulsory licenses for dependent patents (art. 1362 of the Russian Civil Code) were granted to Nativa LLC, a Russian generic company, based on the court decisions (particularly, as a result of the dispute against Celgene on Lenalidomid[2]). [read post]
27 Jan 2021, 2:01 pm
In that decision, the court also did not explain its decision but rather simply cited to another prior case, Celgene Corp. v. [read post]
8 Oct 2020, 9:45 am
The prescription medications targeted by the lawmakers included “Celgene and Bristol Myers Squibb’s Revlimid cancer treatment, which saw its price hiked 23 times since 2005, and Teva’s multiple sclerosis drug Copaxone, which went up in price 27 times since 2007,” reported the independent, nonpartisan Kaiser Health News service. [read post]
25 Aug 2020, 9:41 am
This result comports with the Court’s prior decisions in Celgene Corp. v. [read post]
22 Jun 2020, 8:15 am
Petitions denied: Collabo (retroactive IPR violates due process & takings); Celgene (same); Enzo (Same) Hospira (limits on DOE); CJ CheilJedang (same) Comcast (mootness of ITC decision for expired patent) Federal Circuit decision Vacated & Remanded: Emerson Electric Co. [read post]
4 Jun 2020, 2:58 am
Sony Corporation, No. 19-601; Celgene Corporation v. [read post]
12 May 2020, 9:07 am
Celgene Corp. v. [read post]
11 May 2020, 8:24 pm
Celgene Corp. v. [read post]
23 Apr 2020, 7:18 am
Celgene’s situation is analogous. [read post]
14 Apr 2020, 1:20 pm
Just as it did in other cases raising Patent Trial and Appeal Board (PTAB)-related Takings Clause issues, the appellate court in Golden relied on its July 2019 decision in Celgene Corp. v. [read post]
14 Apr 2020, 1:20 pm
Just as it did in other cases raising Patent Trial and Appeal Board (PTAB)-related Takings Clause issues, the appellate court in Golden relied on its July 2019 decision in Celgene Corp. v. [read post]
6 Apr 2020, 10:03 am
Law professors recently filed an amicus brief in support of the Celgene's petition for writ of certiorari to take up Celgene Corp v. [read post]
6 Apr 2020, 10:03 am
Law professors recently filed an amicus brief in support of the Celgene's petition for writ of certiorari to take up Celgene Corp v. [read post]
19 Feb 2020, 4:03 pm
Indeed, the FTC has required divestitures of on market drugs in Bristol Meyers/Celgene and Amneal/Impax because the Commission generally believes that consumers should not bear the risk that a divestiture may fail. [read post]
21 Nov 2019, 2:15 pm
Nearly four months ago, the Federal Circuit for the first time addressed the applicability of the Takings Clause of the Fifth Amendment to IPRs, holding in Celgene Corp v. [read post]
21 Nov 2019, 2:15 pm
Both Celgene’s en banc petition and the government’s response address the merits of Celgene’s constitutional claim—but as we hinted at in an earlier article analyzing the Celgene decision, there is a serious question whether the Federal Circuit should have even reached the merits of the Takings Clause issue in its panel opinion. [read post]
11 Nov 2019, 9:55 am
[Celgene Petition Rehearing]. [read post]
7 Nov 2019, 8:10 pm
Notable advances include Takeda (up 142% based in part on its Shire acquisition, and jumping in the rankings from 23rd to 17th Q4 2018 – Q1 2019), with several other companies showing robust growth (including Celgene Corp., 37%; Novo Nordisk AS, 17%; Novartis AG, 14%; and Merck KGa, 13%; Hoffmann-La Roche, 12.7%). [read post]
4 Nov 2019, 5:01 am
" Celgene Corp. v. [read post]
15 Oct 2019, 5:27 pm
., Celgene Corp. v. [read post]
